NSCLC	non-small-cell lung cancer
ErbB	erythroblastic oncogene B
EGFR	epidermal growth factor receptor
PTEN	phosphatase and tensin homolog
PI3K	phosphoinositide 3-kinases
MEK	mitogen-activated protein kinase kinase
ERK	extracellular signal-regulated kinases
TKIs	tyrosine kinase inhibitor
RTKs	receptor tyrosine kinases
MET	mesenchymal–epithelial transition factor
HGFs	hepatocyte growth receptors
IGFRs	insulin-like growth factors receptors
FGFRs	fibroblast growth factor receptors
VEGFRs	vascular endothelial growth factor receptors
MET	tyrosine-protein kinase Met
PIK3CA	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha
HGF	hepatocyte growth factor
FGFR	fibroblast growth factor receptors
JAK	Janus kinase
MAPK	mitogen-activated protein kinase
SPRY4	Protein sprouty homolog 4
VEGF	Vascular endothelial growth factor
PJA2	E3 ubiquitin-protein ligase Praja2
SNAIL2	Sal-like protein 2
RR	response rate
ORR	objective response rate
PFS	Progression Free Survival
mPFS	median PFS
OS	overall survival
mOS	median OS
DCR	Disease Control Rate
FDA	Food and Drug Administration
ILD	Interstitial lung disease
QTc	QT interval corrected for heart rate
CNS	central nervous system
EGFR-TFs	EMT-inducing transcription factors